Search

Author/Creator Call, Timothy G.

1. A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG‐ACRIN cancer research group (E1908). Issue 3 (9th February 2016)

Authors:
Zent, Clive S.; Victoria Wang, Xin; Ketterling, Rhett P.; Hanson, Curtis A.; Libby, Edward N.; Barrientos, Jacqueline C.; Call, Timothy G.; Chang, Julie E.; Liu, Jane J.; Calvo, Alejandro R.; Lazarus, Hillard M.; Rowe, Jacob M.; Luger, Selina M.; Litzow, Mark R.; Tallman, Martin S.
Journal:
American journal of hematology
Issue:
Volume 91:Issue 3(2016:Mar.)
Page Start:
308
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare. Issue 3 (13th December 2019)

Authors:
Hampel, Paul J.; Call, Timothy G.; Ding, Wei; Muchtar, Eli; Kenderian, Saad S.; Wang, Yucai; Leis, Jose F.; Witzig, Thomas E.; Koehler, Amber B.; Fonder, Amie L.; Schwager, Susan M.; Rabe, Kari G.; Van Dyke, Daniel L.; Braggio, Esteban; Slager, Susan L.; Kay, Neil E.; Parikh, Sameer A.
Journal:
American journal of hematology
Issue:
Volume 95:Issue 3(2020:Mar.)
Page Start:
E57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Akt inhibitor MK2206 selectively targets CLL B‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis. (20th September 2013)

Authors:
Ding, Wei; Shanafelt, Tait D.; Lesnick, Connie E.; Erlichman, Charles; Leis, Jose F.; Secreto, Charla; Sassoon, Traci R.; Call, Timothy G.; Bowen, Deborah A.; Conte, Michael; Kumar, Shaji; Kay, Neil E.
Journal:
British journal of haematology
Issue:
Volume 164:Number 1(2014:Jan.)
Page Start:
146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma. Issue 3 (8th March 2021)

Authors:
Liebow, Mark; Larson, Melissa C.; Thompson, Carrie A.; Nowakowski, Grzegorz S.; Call, Timothy G.; Macon, William R.; Kay, Neil E.; Habermann, Thomas M.; Slager, Susan L.; Cerhan, James R.
Journal:
International journal of cancer
Issue:
Volume 149:Issue 3(2021)
Page Start:
535
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Issue 7 (3rd July 2017)

Authors:
Shanafelt, Tait D.; Parikh, Sameer A.; Noseworthy, Peter A.; Goede, Valentin; Chaffee, Kari G.; Bahlo, Jasmin; Call, Timothy G.; Schwager, Susan M.; Ding, Wei; Eichhorst, Barbara; Fischer, Kirsten; Leis, Jose F.; Chanan-Khan, Asher Alban; Hallek, Michael; Slager, Susan L.; Kay, Neil E.
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 7(2017)
Page Start:
1630
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. (16th August 2018)

Authors:
Hampel, Paul J.; Larson, Melissa C.; Kabat, Brian; Call, Timothy G.; Ding, Wei; Kenderian, Saad S.; Bowen, Deborah; Boysen, Justin; Schwager, Susan M.; Leis, Jose F.; Chanan‐Khan, Asher A.; Muchtar, Eli; Hanson, Curtis A.; Slager, Susan L.; Kay, Neil E.; Chaffee, Kari G.; Shanafelt, Tait D.; Pari...
Journal:
British journal of haematology
Issue:
Volume 183:Number 3(2018)
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia. (7th April 2017)

Authors:
Strati, Paolo; Parikh, Sameer A.; Chaffee, Kari G; Achenbach, Sara J.; Slager, Susan L.; Call, Timothy G.; Ding, Wei; Jelinek, Diane F.; Hanson, Curtis A.; Kay, Neil E.; Shanafelt, Tait D.
Journal:
British journal of haematology
Issue:
Volume 178:Number 1(2017)
Page Start:
99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Chemoimmunotherapy for relapsed/refractory and progressive 17p13‐deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low‐dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells. Issue 7 (26th April 2014)

Authors:
Zent, Clive S.; Taylor, Ronald P.; Lindorfer, Margaret A.; Beum, Paul V.; LaPlant, Betsy; Wu, Wenting; Call, Timothy G.; Bowen, Deborah A.; Conte, Michael J.; Frederick, Lori A.; Link, Brian K.; Blackwell, Sue E.; Veeramani, Suresh; Baig, Nisar A.; Viswanatha, David S.; Weiner, George J.; Witzig,...
Journal:
American journal of hematology
Issue:
Volume 89:Issue 7(2014:Jul.)
Page Start:
757
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis. Issue 7 (6th June 2020)

Authors:
Bubik, Rachel J.; Barth, Dylan M.; Hook, Christopher; Wolf, Robert C.; Muth, Jessica M.; Mara, Kristin; Patnaik, Mrinal S.; Pruthi, Rajiv K.; Marshall, Ariela L.; Litzow, Mark R.; Elliott, Michelle A.; Hogan, William J.; Shah, Mithun V.; Begna, Kebede H.; Alkhateeb, Hassan; Pardanani, Animesh; As...
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 7(2020)
Page Start:
1592
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗